Skip to main navigation Skip to search Skip to main content

A Randomized, Double-blind, Placebo-controlled Clinical Study to Evaluate Mavacamten in Adolescents (age 12 years to < 18 years) with Symptomatic Obstructive Hypertrophic Cardiomyopathy.

Project: Research

Project Details

StatusActive
Effective start/end date17/07/24 → 15/04/28

Clinical Trial Phase

  • Phase III (a & b)